| 注册
首页|期刊导航|中国耳鼻咽喉头颈外科|过氧化物酶体增殖物激活受体γ激动剂对小鼠变应性鼻炎治疗的作用与机制研究

过氧化物酶体增殖物激活受体γ激动剂对小鼠变应性鼻炎治疗的作用与机制研究

姜婷婷 李欣倩 朱静静 闫勇 吴曙辉

中国耳鼻咽喉头颈外科2019,Vol.26Issue(2):79-83,5.
中国耳鼻咽喉头颈外科2019,Vol.26Issue(2):79-83,5.DOI:10.16066/j.1672-7002.2019.02.006

过氧化物酶体增殖物激活受体γ激动剂对小鼠变应性鼻炎治疗的作用与机制研究

Effect and mechanism of PPAR gamma agonist on allergic rhinitis in mice

姜婷婷 1李欣倩 1朱静静 1闫勇 1吴曙辉1

作者信息

  • 1. 上海市宝山区中西医结合医院耳鼻咽喉科, 上海 201900
  • 折叠

摘要

Abstract

OBJECTIVE To invest igate the therapeutic effect and mechanism of PPAR gamma agonist on allergic rhinitis(AR) in mice. METHODS AR murine model was established by OVA sensitization and challenge. The behavior observation was used to understand the improvement effect of PIO on AR symptoms. The morphological characteristics of nasal tissues were observed by HE staining. The total RNA was extracted to investigate the level of mRNA expression of Foxp3, T-bet and GATA-3. The changes of CD4+Foxp3+T cells in spleen of mice were analyzed by flow cytometry. RESULTS BALB/c mice received OVA sensitization followed by OVA intranasal challenge, the frequencies of sneezing and nose-scratching increased signif icantly in AR group compared with control group. The frequencies decreased significantly in PIO group, compared with AR group. The continuity of nasal mucosa ciliated columnar epithelium in AR group was destroyed and appeared to be repaired in PIO group. Inflammatory cells infiltration was also markedly decreased by PIO treatment. PIO significantly increased the expression of Foxp3 mRNA(P <0.001) compared with AR and control group. There was no significant difference in T-bet between PIO group and AR group, but the expression of GATA-3 mRA in PIO group was significantly lower than AR group. The proportion of CD4+Foxp3+T cells in AR group (4.43%±0.25%) decreased compared with control group (5.19%±0.39%) (P <0.001). PIO treatment induced production of Tregs (6.35%±0.37%) compaered with control group(P <0.001). CONCLUSION PPAR-gamma agonist can effectively alleviate allergic symptoms of mice and regulate the balance of Th1/Th2. The role of PPAR gamma agonist in the treatment of AR may be the amplification of Tregs by promoting Foxp3 expression.

关键词

鼻炎,变应性,常年性/鼻炎,变应性,季节性/过氧化物酶体增殖物激活受体/叉头转录因子类/T淋巴细胞/Th1-Th2平衡

Key words

Rhinitis, Allergic, Perennial/Rhinitis, Allergic, Seasonal/Peroxisome Proliferator-Activated Receptors/Forkhead Transcription Factors/T-Lymphocytes/Th1-Th2 Balance

引用本文复制引用

姜婷婷,李欣倩,朱静静,闫勇,吴曙辉..过氧化物酶体增殖物激活受体γ激动剂对小鼠变应性鼻炎治疗的作用与机制研究[J].中国耳鼻咽喉头颈外科,2019,26(2):79-83,5.

基金项目

上海市宝山区卫生青年医学人才培养计划(bswsyq-2015-A11) (bswsyq-2015-A11)

中国耳鼻咽喉头颈外科

OACSCDCSTPCD

1672-7002

访问量0
|
下载量0
段落导航相关论文